Cellebrite Di Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cellebrite Di Ltd (CLBT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Cellebrite Di Ltd vs Its Competitors
- TTM: Trailing 12-month revenue of 476M vs 1,289,159M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs accelerating (+5.9%) for its tracked peer group.
- Growth: Cellebrite Di Ltd generated 18.7% revenue growth year over year in Q4 2025, vs 10.2% for its tracked competitors combined.
- Profitability: Its 16.4% net margin compares with 21.3% for the peer group.
- Scale: Cellebrite Di Ltd ranks #84 of 260 companies by market capitalization in the Software & Programming industry, holding 0.0% of industry market cap.
- Peer revenue share: Cellebrite Di Ltd accounted for 0.1% of combined revenue among its tracked peer group, up from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.37M compares with $0.55M for the peer group (0.7x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CLBT Sales vs. its Competitors, Q4 2025
Cellebrite Di Ltd reported revenue growth of 18.69 % year on year in Q4 2025, above its competitors' combined revenue growth of 10.20 %.
With a net margin of 16.36 %, Cellebrite Di Ltd reported lower profitability than its competitors (21.33 %).
Cellebrite Di Ltd generated 0.14 % of the combined sales of its peer group, up from 0.13 % a year earlier.
Cellebrite Di Ltd vs. its Competitors, Q4 2025
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Cellebrite Di Ltd and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Cellebrite Di Ltd | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (10) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (7) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Cellebrite Di Ltd's competitor groups requires a Commercial License.
For context: the Software & Programming industry grew revenue 16.0% year over year, combined, vs 18.7% for Cellebrite Di Ltd. Cellebrite Di Ltd's share of combined industry revenue moved from 0.14% to 0.15%, a gain of 0.00 percentage points.
Cellebrite Di Ltd's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Cellebrite Di Ltd | Yes | Yes | Yes | Yes |
| Competitors combined (31) | ||||
| High-Confidence Competitors (2) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 37.50 % (3 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CLBT Stock Performance relative to its Competitors
CLBT Stock Performance relative to High-Confidence Competitors
CLBT Stock Performance relative to Similar-Size Competitors
CLBT Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Fastly Inc | 282.9% | Outperformed |
| 2 | Datadog Inc | 282.9% | Outperformed |
| 3 | Jfrog Ltd | 282.9% | Outperformed |
| 4 | Solarwinds Corporation | 282.9% | Outperformed |
| 5 | Cloudflare Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Cellebrite Di Ltd's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Cellebrite Di Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Cellebrite Di Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Cellebrite Di Ltd | 2,766.43 | 475.50 |
| Microsoft Corporation | 3,795,216.66 | 331,839.00 |
| Amazon com Inc | 2,683,773.45 | 776,231.00 |
| Palantir Technologies Inc | 481,578.75 | 6,156.87 |
| Oracle Corporation | 397,830.00 | 73,266.00 |
| International Business Machines Corporation | 210,356.66 | 69,096.00 |
| SUBTOTAL | 8,005,743.46 | 1,295,812.61 |
Sign in to see all competitors of Cellebrite Di Ltd .
Sources: Cellebrite Di Ltd's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Cellebrite Di Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Cellebrite Di Ltd's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| GrayShift | Named by the company | 85% |
| MSAB | Named by the company | 85% |
| Motorola | Named by the company | 85% |
| Babel Street | Named by the company | 85% |
| Microsystemation AB | Named by the company | 85% |
| OpenText | Named by the company | 85% |
| Harris (i2) | Named by the company | 85% |
| NICE | Named by the company | 85% |
| Exterro | Named by the company | 85% |
| Motorola | Named by the company | 85% |
| Oxygen Forensics, Inc. | Named by the company | 85% |
| Magnet Forensics | Named by the company | 85% |
| Nuix | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Cellebrite Di Ltd's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Cellebrite Di Ltd's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Microsoft Corporation | Productivity and Business Processes 42.19 % |
| Amazon com Inc | North America 57.75 % |
| Palantir Technologies Inc | Government Operating 51.15 % |
| Oracle Corporation | Cloud and Software Business 83.96 % |
| International Business Machines Corporation | Software 45.22 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Cellebrite Di Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Cellebrite Di Ltd | 2,766 | 370,041 | 60,555 |
| Microsoft Corporation | 3,795,217 | 1,488,067 | 599,771 |
| Amazon com Inc | 2,683,773 | 492,532 | 85,838 |
| Palantir Technologies Inc | 481,579 | 1,390,126 | 684,290 |
| Oracle Corporation | 397,830 | 519,617 | 134,184 |
| International Business Machines Corporation | 210,357 | 226,322 | 35,129 |
| PEERS TOTAL | 8,002,977 | 552,819 | 130,740 |
Sign in to see all peers for Cellebrite Di Ltd .
Cellebrite Di Ltd's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Cellebrite Di Ltd | Americas 53.96 % |
| Microsoft Corporation | US 51.47 % |
| Oracle Corporation | Americas 63.46 % |
| International Business Machines Corporation | Americas 49.04 % |
| Cloudflare Inc | United States 49.38 % |
| Datadog Inc | North America 71.95 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Cellebrite Di Ltd .
Cellebrite Di Ltd's Position in Industry Market Structure
Market-capitalization share and concentration across all 236 companies in Cellebrite Di Ltd's industry classification, broader than the peer set above. Market cap in millions of $.Cellebrite Di Ltd ranks #84 of 236 companies by market capitalization in its industry, holding 0.04 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 2,661, indicating a highly concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Microsoft Corporation | 3,756,759 | 50.30 % |
| 2 | Palantir Technologies Inc | 486,305 | 6.51 % |
| 3 | Oracle Corporation | 388,902 | 5.21 % |
| 4 | Sap Se | 268,701 | 3.60 % |
| 5 | Crowdstrike Holdings Inc | 1,234 | 5.2% |
| 6 | Salesforce Inc | 1,234 | 5.2% |
| 7 | Shopify Inc | 1,234 | 5.2% |
| 8 | Full Truck Alliance Co Ltd | 1,234 | 5.2% |
| 9 | Servicenow Inc | 1,234 | 5.2% |
| 10 | Cloudflare Inc | 1,234 | 5.2% |
| 84 | Cellebrite Di Ltd | 2,656 | 0.04 % |
Market cap and industry share for the rest of Cellebrite Di Ltd's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Cellebrite Di Ltd's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 79 | Alarm com Holdings Inc | 2,948 | 2.79 % |
| 80 | Sps Commerce Inc | 2,919 | -23.96 % |
| 81 | Avepoint Inc | 2,798 | -16.75 % |
| 82 | Intapp Inc | 2,779 | -16.96 % |
| 83 | Teradata Corporation | 1,234 | 12.3% |
| 84 | Cellebrite Di Ltd | 2,656 | -41.91 % |
| 85 | Soundhound Ai Inc | 1,234 | 12.3% |
| 86 | Braze Inc | 1,234 | 12.3% |
| 87 | Appian Corporation | 1,234 | 12.3% |
| 88 | Via Transportation Inc | 1,234 | 12.3% |
| 89 | Pdf Solutions Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Cellebrite Di Ltd's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Cellebrite Di Ltd's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Software & Programming industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (343 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 84.23 % | 64.28 % (avg) | +19.9 pp |
| Operating Margin | 13.98 % | industry median | +16.5 pp |
| EBITDA Margin | 21.57 % | 2.53 % (avg) | +19.0 pp |
| Capital Intensity (Capex / Revenue) | - | 4.79 % (avg) | - |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Cellebrite Di Ltd's Valuation vs Competitive Position
Valuation multiples vs the Software & Programming industry average (343 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 57.9x | 39.5x | +18.5x |
| EV / EBITDA | 42.4x | 21.7x | +20.7x |
| P/B | 9.3x | 5.4x | +3.9x |
| Return on Equity | 16.07 % | industry aggregate | -6.49 % |
| Return on Invested Capital | 5.89 % | -0.26 % (avg) | 6.15 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Cellebrite Di Ltd's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | 31.93 % | 23.31 % | 18.69 % |
| Operating Margin | 0.32 % | 14.20 % | 13.98 % |
| Return on Invested Capital | 0.16 % | 7.21 % | 5.89 % |
| P/E | 13.2x | - | 57.9x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Cellebrite Di Ltd's Strategic Group Map
Every company in Cellebrite Di Ltd's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Cellebrite Di Ltd is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Cellebrite Di Ltd's BCG Growth-Share Matrix
Relative market share (vs Cellebrite Di Ltd's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Cellebrite Di Ltd falls in the Question Mark quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 11.6% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Microsoft Corporation alone holds 50% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Cellebrite Di Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Low | Industry HHI of 2,661 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Cellebrite Di Ltd's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Cellebrite Di Ltd's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Cellebrite Di Ltd's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Cellebrite Di Ltd falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Cellebrite Di Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 16.5 points above the industry median.
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
- Return on equity 6.5 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- Industry revenue growing at a healthy 11.6% median pace.
Threats
- Industry dominated by Microsoft Corporation, holding 50.30 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Cellebrite Di Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Cellebrite Di Ltd | 0.37 | 1.56 | - |
| Microsoft Corporation | 0.13 | 1.31 | 0.11 |
| Amazon com Inc | 0.38 | 1.07 | 0.21 |
| Palantir Technologies Inc | 1.40 | 6.94 | - |
| Oracle Corporation | 0.72 | 1.12 | 2.83 |
| International Business Machines Corporation | 0.29 | 0.87 | 3.47 |
Sign in to see all peers for Cellebrite Di Ltd .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Cellebrite Di Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Cellebrite Di Ltd | Q4 2025 | +18.7 % | - |
| Microsoft Corporation | Q2 2026 | +17.7 % | +31.3 % |
| Amazon com Inc | Q2 2026 | +19.9 % | +244.9 % |
| Palantir Technologies Inc | Q2 2026 | +93.0 % | +224.4 % |
| Oracle Corporation | Q3 2026 | +24.0 % | +62.6 % |
| International Business Machines Corporation | Q2 2026 | +1.1 % | -1.3 % |
| PEERS TOTAL | +18.6 % | +113.1 % |
Sign in to see all peers for Cellebrite Di Ltd .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Cellebrite Di Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Cellebrite Di Ltd | Q4 2025 | +20.1 % | - |
| Microsoft Corporation | Q2 2026 | +22.9 % | +109.6 % |
| Amazon com Inc | Q2 2026 | +18.5 % | +300.3 % |
| Palantir Technologies Inc | Q2 2026 | +54.6 % | +90.6 % |
| Oracle Corporation | Q3 2026 | - | +235.2 % |
| International Business Machines Corporation | Q2 2026 | +3.6 % | +9.0 % |
Sign in to see all peers for Cellebrite Di Ltd .
Cellebrite Di Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Cellebrite Di Ltd | 8.29% | 12.08% | 16.07% |
| Microsoft Corporation | 19.76% | 22.48% | 34.22% |
| Amazon com Inc | 15.21% | 23.40% | 30.50% |
| Palantir Technologies Inc | 31.17% | 34.61% | 37.17% |
| Oracle Corporation | 7.73% | 9.84% | 44.45% |
| International Business Machines Corporation | 7.07% | 7.03% | 33.43% |
Sign in to see all peers for Cellebrite Di Ltd .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Cellebrite Di Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Cellebrite Di Ltd | 35.71 | 5.82 |
| Microsoft Corporation | 28.37 | 11.44 |
| Amazon com Inc | 19.79 | 3.46 |
| Palantir Technologies Inc | 160.24 | 78.22 |
| Oracle Corporation | 20.79 | 5.43 |
| International Business Machines Corporation | 19.55 | 3.04 |
| PEERS AVERAGE | 26.13 | 6.18 |
Sign in to see all peers for Cellebrite Di Ltd .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.